“Aakha Biologics has been consistently sourcing high-quality human primary immune cells, including PBMCs, NK cells, and CD8⁺ T cells—from IQ Biosciences to support our in vitro and in vivo evaluation of immune-cell-engaging biologics. These cells are integral to our NSG mouse humanization workflows as well as downstream functional assays assessing immune activation, cytotoxicity, and therapeutic efficacy.
We have been very satisfied with the quality, consistency, and performance of IQ Biosciences’ products across multiple experimental platforms. The cells have demonstrated reliable engraftment and functional robustness, enabling reproducible and interpretable results in our preclinical studies.
As our programs continue to advance, we look forward to expanding our collaboration with IQ Biosciences and sourcing additional immune cell types to support our growing research and development needs.”
Manoj Sabnani, MS
Aakha Biologics
“The cells performed exceptionally well in our experiments, consistently showing high viability and no signs of contamination, which greatly contributed to the success of our research.”
Lang Hu, Protheragen
